Controversial issues and and optimal management of stage T1G3 bladder cancer

被引：10

作者：

Metwalli, Adam R. ^{[1
]}

Kamat, Ashish M. ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Urol, Unit 1373, Houston, TX 77030 USA

来源：

EXPERT REVIEW OF ANTICANCER THERAPY | 2006年 / 6卷 / 08期

关键词：

cystectomy; intravesical therapy; T1G3 bladder cancer; urothelial carcinoma; BACILLUS-CALMETTE-GUERIN; TRANSITIONAL-CELL-CARCINOMA; IMMEDIATE POSTOPERATIVE INSTILLATION; INDUCED FLUORESCENCE DIAGNOSIS; 2ND TRANSURETHRAL RESECTION; INTRAVESICAL MITOMYCIN-C; P53; OVER-EXPRESSION; IN-SITU; RADICAL CYSTECTOMY; 5-AMINOLEVULINIC ACID;

D O I：

10.1586/14737140.6.8.1283

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The management of T1G3 bladder cancer is controversial. Diagnostic methods, such as bladder mapping or second-look transurethral resection are recommended to assess risk. Bacillus Calmeffe-Guerin intravesical therapy with a maintenance regimen is recommended for solitary T1G3 tumors. The timing of radical cystectomy for these patients is controversial, but early recurrence during intravesical therapy is an indication for radical cystectomy. Multifocal disease, concomitant carcinoma in situ and disease in the prostatic urethra and bladder neck also suggest aggressive disease and cystectomy should be considered in these patients.

引用

页码：1283 / 1294

页数：12

共 120 条

[1]

Alvarado-Cabrero Isabel, 2005, Ann Diagn Pathol, V9, P1, DOI 10.1053/j.anndiagpath.2004.10.001

[2] MICROPAPILLARY VARIANT OF TRANSITIONAL-CELL CARCINOMA OF THE URINARY-BLADDER - HISTOLOGIC PATTERN RESEMBLING OVARIAN PAPILLARY SEROUS CARCINOMA [J].

AMIN, MB ;

RO, JY ;

ELSHARKAWY, T ;

LEE, KM ;

TRONCOSO, P ;

SILVA, EG ;

ORDONEZ, NG ;

AYALA, AG .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1994, 18 (12) :1224-1232

[3] RADICAL CYSTECTOMY FOR STAGE-TA, STAGE-TIS AND STAGE-T1 TRANSITIONAL-CELL CARCINOMA OF THE BLADDER [J].

AMLING, CL ;

THRASHER, JB ;

FRAZIER, HA ;

DODGE, RK ;

ROBERTSON, JE ;

PAULSON, DF .

JOURNAL OF UROLOGY, 1994, 151 (01) :31-36

[4] 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer [J].

Babjuk, M ;

Soukup, V ;

Petrík, R ;

Jirsa, M ;

Dvorácek, J .

BJU INTERNATIONAL, 2005, 96 (06) :798-802

[5] Intravesical bacillus Calmette-Guerin treatment for stage T1 grade 3 transitional cell carcinoma of the bladder [J].

Baniel, J ;

Grauss, D ;

Engelstein, D ;

Sella, A .

UROLOGY, 1998, 52 (05) :785-789

[6] Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study [J].

Berger, AP ;

Steiner, H ;

Stenzl, A ;

Akkad, T ;

Bartsch, G ;

Holtl, L .

UROLOGY, 2003, 61 (02) :338-341

[7] The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma [J].

Bernardini, S ;

Billerey, C ;

Martin, M ;

Adessi, GL ;

Wallerand, H ;

Bittard, H .

JOURNAL OF UROLOGY, 2001, 165 (01) :42-46

[8] The management of T1G3 bladder cancer [J].

Bogdanovic, J ;

Marusic, G ;

Djozic, J ;

Sekulic, V ;

Budakov, P ;

Dejanovic, N ;

Stojkov, J .

UROLOGIA INTERNATIONALIS, 2002, 69 (04) :263-265

[9]

Böhle A, 2004, UROLOGY, V63, P682, DOI 10.1016/j.urology.2003.11.049

[10] Transurethral resection and sequential chemo-immunoprophylaxis in primary T1G3 bladder cancer [J].

Bono, AV ;

Lovisolo, JA ;

Saredi, G .

EUROPEAN UROLOGY, 2000, 37 (04) :478-482

← 1 2 3 4 5 6 7 8 9 10 →